Coronavirus screening for students of the Faculty of Medicine
A number of coronavirus infections have been diagnosed among first-year students of medicine and dentistry at the Faculty of Medicine, University of Helsinki. All first-year students of the Faculty of Medicine who attended an extracurricular student event on 27 August will be screened for coronavirus infection.

The students at the Faculty of Medicine who participated in an extracurricular event held for students on 27 August may have been exposed to coronavirus. To ensure patient safety and prevent the spread of infections, all participants are to attend teaching remotely until 8 September. All event participants should avoid social contact, and they will be screened for coronavirus.

Clinical teaching for other students of the Faculty of Medicine and the professional duties of the teaching staff will continue to be carried out by observing intensified hygiene procedures. Contact teaching must not be attended when experiencing even minor symptoms associated with COVID-19.

“Healthcare customers can continue to safely visit health centres, hospitals and other healthcare units. The City of Helsinki, the Hospital District of Helsinki and Uusimaa and the University of Helsinki are closely cooperating on the matter, and patient safety has not been compromised,” says Dean Risto Renkonen of the Faculty of Medicine.

The Epidemiologic operations unit of the City of Helsinki will contact all individuals identified as having been in close contact with the infected individuals.

To prevent the spread of coronavirus infections, the Epidemiologic operations unit of the City of Helsinki, in cooperation with the Faculty of Medicine and the Epidemiological Unit of the Hospital District of Helsinki and Uusimaa, has decided to recommend that all first-year students of medicine and dentistry at the Faculty be moved to remote instruction for two weeks, from 2 to 16 September 2020.

When necessary, the University’s teaching staff can contact their occupational healthcare provider.

The epidemiologic investigations will continue, and further announcements will be made as necessary.